Merck & Co., Inc.
CIK
310158
Location
RAHWAY, NJ
Portfolio Value
Small
$526,407,164
Diversification
Highly concentrated
Reports for
MERCK SHARP & DOHME LLC
Filing Date
Global Rank
#2,776
/ 8,700
▲ 1771
Top Industry
Biotechnology
64.2%
Period ended 2 months ago
Filed Aug 7, 2026 · 37d
7 quarters · since Dec 2024
Portfolio Concentration
13 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
35.8%
−0.1 pts
Top 5
93.2%
−0.1 pts
Top 10
99.8%
−0.2 pts
HHI
2,567
Highly concentrated+84
Portfolio Trend
7 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $526,407,164 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | 1,739,768 | $12,804,692 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| — | 1,473,240 | $0 | ||
| No positions match the current search. | ||||
13 tracked positions ·
$526,407,164 total
· filing declares
13 positions · $526,407,169
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PSNL |
Personalis, Inc.
Healthcare
|
Held | 14,044,943 | $188,202,236 | 35.75% | |
| MRNA |
Moderna, Inc.
Healthcare
|
Held | 2,308,190 | $161,642,545 | 30.71% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Held | 772,165 | $88,544,160 | 16.82% | |
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
Held | 952,844 | $30,710,162 | 5.83% | |
| EIKN |
Eikon Therapeutics, Inc.
Healthcare
|
Held | 1,666,666 | $21,749,991 | 4.13% | |
| TRDA |
Entrada Therapeutics, Inc.
Healthcare
|
NEW | 1,739,768 | $12,804,692 | 2.43% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Held | 272,351 | $9,042,053 | 1.72% | |
| ALEC |
Alector, Inc.
Healthcare
|
Held | 3,545,719 | $7,126,895 | 1.35% | |
| EVAX |
Evaxion A/S
Healthcare
|
Held | 1,214,126 | $3,763,790 | 0.71% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Held | 93,414 | $1,716,015 | 0.33% | |
| XLO |
Xilio Therapeutics, Inc.
Healthcare
|
Held | 105,982 | $1,015,307 | 0.19% | |
| HURA |
TuHURA Biosciences, Inc./NV
Healthcare
|
Held | 19,445 | $45,501 | 0.01% | |
| NEUP |
Neuphoria Therapeutics Inc.
Healthcare
|
Held | 10,027 | $43,817 | 0.01% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.